Molecular Diagnostics Market By Product (Reagents And Kits, Instruments, Services And Software), By Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Insitu Hybridization, Microarray), By Application (Infectious Disease, Oncology, Next Generation Sequencing, Dna Sequencing, Microbiology ) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on global molecular diagnostics market studies various products, applications and technologies used in the field of molecular diagnostics. Increasing number of patients suffering with chronic illnesses requiring prompt diagnosis, rising demand for personalized medication, advent of pharmacogenomics and government initiatives in promoting public health and welfare will propel the molecular diagnostics market. The limiting factors related to this market is the complex regulatory scenario for approvals to molecular diagnostic kits which vary according to countries. Technological advancement in the design and manufacture of diagnostic kits will result into deep market penetration of the molecular diagnostics solutions in the market.

For the purpose of this study, the various products studied include reagents and kits, instruments, services and software; applications studied for the purpose of this research are segmented as infectious disease, oncology, next generation sequencing, DNA sequencing, microbiology and others. The molecular diagnostic technologies are further categorized as polymerase chain reaction, isothermal nucleic acid amplification technology, in situ hybridization, microarray and others. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global molecular diagnostics market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global molecular diagnostics market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key players currently enjoying prominent position in the global molecular diagnostics market. The key players profiled in this report are Abbott Laboratories, Inc., Alere, Inc., Bayer AG, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffman La-Roche Ltd., Novartis AG, Qiagen N.V., Siemens Healthcare, and Sysmex Corporation.

Molecular Diagnostics Market

Based on application areas, the global molecular diagnostics market is categorized into

  • Infectious Diseases
  • Oncology
  • Next Generation Sequencing
  • DNA Sequencing
  • Microbiology
  • Others

Molecular Diagnostics Market

Molecular diagnostics is utilized for identification of biological markers in the human genome in order to identify gene expression respective to diseases. It is very vital in the early diagnosis of life threatening diseases where effective treatment regimen is considered immediately. Emergence of infectious diseases such as from Ebola virus and Zika virus, where early disease etiology and symptoms are difficult to detect and interpret, drives the need for molecular diagnosis. Molecular diagnostics helps to decide treatment regimen in accordance to the nature of disease and patients.

Among the considered application areas, infectious diseases hold the largest market in the application segment for the base year 2016, chiefly due to factors such as rising prevalence of infectious diseases, increasing number of primary healthcare centers in both the developed and developing worlds, government initiatives and healthcare expenditure to fight fatal disease like malaria, cholera, tuberculosis, AIDS and HPV. Oncology will be the fastest growing market in the application segment throughout the forecast period 2017-2025, due to increasing number of patients suffering with cancer, rising public awareness leading to early disease diagnosis and treatment, evolved reimbursement scenario regarding disease diagnosis.

Based on technology, the global molecular diagnostics market is categorized into

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology
  • In situ Hybridization
  • Microarrays
  • Others

Molecular Diagnostics Market

Molecular diagnostic techniques are crucial in healthcare management as they are useful in improving patient care, contribute to protect consumer health, and assistive in limiting the healthcare expenditure, which is a major economic issue throughout the world. Rising public awareness and inclination towards healthy and hygienic lifestyle, outbreak of pandemic diseases and increasing number of primary healthcare centers and supportive regulatory approval for molecular diagnostic products and services are the factors that propel the growth of global molecular diagnostics market. In 2016, polymerase chain reaction (PCR) was observed to be the largest technology segment. Vitality of PCR technology in early detection of rare diseases, rising demand for personalized medication and pharmacogenomics, and assistance in establishing DNA sequence of patients which will be helpful in the prevention of several life threatening diseases are the key factors driving this segment. Microarray will be the fastest growing market in the technology segment throughout the forecast period 2017-2025, majorly due to its ability to detect different types of cancer on the basis of the patterns of gene activity in the tumor cells; increasing demand for toxicogenomics in determining antibiotics treatment due to rising prevalence of drug resistant bacterial infection. Overall, the global molecular diagnostics market is highly competitive with presence of multiple players like F.Hoffman La-Roche Ltd., Abbott Laboratories, Novartis AG, Alere, Inc., Siemens Healthcare, Bayer AG, Becton, Dickinson and Company etc. specializing in respective fields.

For the purpose of this study, the global molecular diagnostics market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Molecular Diagnostics Market

North America was observed as the largest market for molecular diagnostics in the base year 2016. The dominance of North America market is mainly attributed to rising number of infectious diseases requiring immediate diagnosis, increased government healthcare expenditure to promote public health and wellbeing and favorable reimbursement scenario. Europe is expected to be the second largest market due to high prevalence of cancer, technological advancement in diagnostic techniques and positive regulatory approval for molecular diagnostic products. Asia Pacific will be the fastest growing market for the forecast period 2017-2025, the factors that propel the market growth are large patient pool undergoing diagnosis for chronic diseases, infections and cancer, rise in market competition due to presence of existing and budding manufactures involved in production of molecular diagnostic solutions, and increasing disposable income in these regions. Factors such as development of large number of primary healthcare centers in remote areas, increasing disease awareness and increasing demand for molecular diagnostics are going to fuel the rapid growth of molecular diagnostic market in Latin America and Middle East and Africa region in the near future.   

Choose License Type
Published Date:  Jul 2017
Category:  Biotechnology
Report ID:   58588
Report Format:   PDF
Pages:   120
Rating:    4.5 (40)
Connect With Us
+1-408-641-3282
24/7 Research Support